J9600 HCPCS Level II code: Injection, porfimer sodium, 75 mg
J9600 is the HCPCS code for “Injection, porfimer sodium, 75 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J9600Injection, porfimer sodium, 75 mg
Short description: Porfimer sodium injection
HCPCS · United States
Medicare details
The indicators CMS publishes with J9600 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Chemotherapy
- Added
- Jan 1, 1998
Where J9600 sits
- 1J codesDrugs administered other than orally
- 2Active code J9600Injection, porfimer sodium, 75 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J9600 mean?
J9600 is the HCPCS code for “Injection, porfimer sodium, 75 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J9600?
CMS lists J9600’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9600
All J codesJ9382Injection, zenocutuzumab-zbco, 1 mgJ9390Injection, vinorelbine tartrate, 10 mgJ9393Injection, fulvestrant (teva), not therapeutically equivalent to j9395, 25 mgJ9394Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mgJ9395Injection, fulvestrant, 25 mgJ9400Injection, ziv-aflibercept, 1 mgJ9601Injection, linvoseltamab-gcpt, 1 mgJ9999Not otherwise classified, antineoplastic drugs